Atlas Trials

Trial to Describe the Safety and Immunogenicity of Fluzone®

Clinical trial NCT00524940 · COMPLETED

Trial details

NCT number
NCT00524940
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Influenza
Start date
2007-08-01
Primary completion
2007-09-01
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.